Similar companies to Amyris

Amyris is a biotechnology company that utilizes synthetic biology to engineer microorganisms and produce sustainable products. They focus on developing renewable and eco-friendly alternatives to petroleum-based products. Amyris uses their proprietary technology to design pathways in microorganisms, enabling them to convert plant sugars into targeted molecules. These molecules can be used in a wide range of applications such as fragrances, flavors, cosmetics, personal care products, and industrial chemicals. The company aims to promote a more sustainable future by offering high-performance, cost-effective, and environmentally friendly solutions. Amyris collaborates with various partners and customers to commercialize their products and create a positive impact on the planet. Below is the list of lookalike companies of Amyris:

Amyris Logo Amyris
United States
1001-5000 employees
Biotechnology Research
Kemin Industries Logo Kemin Industries
United States
1001-5000 employees
Biotechnology Research
39
similarity score
Ginkgo Bioworks, Inc. Logo Ginkgo Bioworks, Inc.
United States
501-1000 employees
Biotechnology Research
38
similarity score
Galatea Biotech Logo Galatea Biotech
United States
501-1000 employees
Biotechnology Research
38
similarity score
Labconscious Logo Labconscious
United States
1-10 employees
Biotechnology Research
38
similarity score
+500 more lookalike companies

People also ask:

What products does Amyris make?
Amyris was founded in 2003. The company owns three brands, Biossance and Pipette, for beauty and skincare, and Purecane, a sugar substitute.
Who owns Amyris?
Top 10 Owners of Amyris Inc The Vanguard Group, Inc. SSgA Funds Management, Inc. Pinnacle Associates Ltd. Tanaka Capital Management, Inc.
Is Amyris a good company?
Is Amyris a good company to work for? Amyris has an overall rating of 3.2 out of 5, based on over 373 reviews left anonymously by employees. 51% of employees would recommend working at Amyris to a friend and 34% have a positive outlook for the business. This rating has decreased by -20% over the last 12 months.
Is Amyris a good stock to buy?
Amyris has 338.05% upside potential, based on the analysts' average price target. Amyris has a conensus rating of Hold which is based on 1 buy ratings, 3 hold ratings and 0 sell ratings. The average price target for Amyris is $1.98.
How do you find similar companies to Amyris?
We look into multiple data points: CPP ads data, company description, company employee experience and skills. We also use AI to summarize and extract keywords from the home page of Amyris and compare that with other companies.

Similarity score

500x500

We look into multiple data points to determine company similarity score. These data points include:

CPA data

keywords companies bid on display ads on search engines

Company description keywords

Including industry indicators and specialties

Employee description keywords

what people actually do at the company

Publicly available comparison data

such as reviews of competing products/services

Discover ready-to-buy accounts and prospects based on billions of company data signals and attributes.